Indeed, the data show that when IL-2/IL-12-activated NK cells were switched into glutamine-deficient conditions, metabolic rates of OXPHOS and glycolysis decreased dramatically and IFNγ production and tumour cytotoxicity was substantially inhibited. The gene discussed is IFNG; the disease is neoplasm.